-
Regeneron Pharmaceuticals (NASDAQ:REGN) Releases Earnings Results, Beats Expectations By $0.86 EPS
Source: Buzz FX / 05 Feb 2025 15:16:09 America/New_York
Regeneron Pharmaceuticals (NASDAQ:REGN) Releases Earnings Results, Beats Expectations By $0.86 EPS Written by MarketBeat February 5, 2025 Share Link copied to clipboard. Regeneron Pharmaceuticals ( NASDAQ:REGN - Get Free Report ) announced
Read more...